Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

(2022) Christopher JL Murray et al.   LANCET

Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics

(2022) Jayaseelan Murugaiyan et al.   Antibiotics-Basel

Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms

(2022) Cheng Len Sy et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

New antimicrobial peptide-antibiotic combination strategy for Pseudomonas aeruginosa inactivation

(2022) Wenxu Han et al.   Biointerphases

Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates

(2021) Gianluca Morroni et al.   Future Microbiology

Pathogenesis of Gram-Negative Bacteremia

(2021) Caitlyn L. Holmes et al.   CLINICAL MICROBIOLOGY REVIEWS

Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic Solutions

(2021) Loukas Kakoullis et al.   Antibiotics-Basel

Synthesis and antibacterial study of cell-penetrating peptide conjugated trifluoroacetyl and thioacetyl lysine modified peptides

(2021) Kamal D. Patel et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Application of the Resazurin Cell Viability Assay to Monitor Escherichia coli and Salmonella Typhimurium Inactivation Mediated by Phages

(2021) Pedro Costa et al.   Antibiotics-Basel

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent

(2021) Kylen E. Ridyard et al.   Antibiotics-Basel

Evaluation of LL ‐37 in healing of hard‐to‐heal venous leg ulcers: A multicentric prospective randomized placebo‐controlled clinical trial

(2021) Margit Mahlapuu et al.   WOUND REPAIR AND REGENERATION

Silver Nanoparticles Functionalized With Antimicrobial Polypeptides: Benefits and Possible Pitfalls of a Novel Anti-infective Tool

(2021) Maria S. Zharkova et al.   Frontiers in Microbiology

The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design

(2020) Angel León-Buitimea et al.   Frontiers in Microbiology

Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance

(2020) Carole Ayoub Moubareck   Membranes

Effect of N-methylated and fatty acid conjugation on analogs of antimicrobial peptide Anoplin

(2020) Tianqi Liu et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Why big pharma has abandoned antibiotics

(2020) Benjamin Plackett   NATURE

The population genetics of pathogenic Escherichia coli

(2020) Erick Denamur et al.   NATURE REVIEWS MICROBIOLOGY

The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics

(2020) Enea Sancho-Vaello et al.   Scientific Reports

Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates

(2020) Abolfazl Jahangiri et al.   MICROBIAL PATHOGENESIS

D-LL-31 enhances biofilm-eradicating effect of currently used antibiotics for chronic rhinosinusitis and its immunomodulatory activity on human lung epithelial cells

(2020) Saharut Wongkaewkhiaw et al.   PLoS One

Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria

(2020) Ningyi Zhu et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Expansion of antibacterial spectrum of xanthorrhizol against Gram-negatives in combination with PMBN and food-grade antimicrobials

(2019) Man Su Kim et al.   JOURNAL OF MICROBIOLOGY

Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa

(2019) Regina Geitani et al.   BMC MICROBIOLOGY

Comparative mode of action of the antimicrobial peptide melimine and its derivative Mel4 against Pseudomonas aeruginosa

(2019) Muhammad Yasir et al.   Scientific Reports

Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics—A Novel Way to Combat Antibiotic Resistance?

(2019) Maria S. Zharkova et al.   Frontiers in Cellular and Infection Microbiology

Design and characterization of a new hybrid peptide from LL-37 and BMAP-27

(2019) Yara Al Tall et al.   Infection and Drug Resistance

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms

(2019) Jason Kang et al.   PLoS One

Improving therapy of severe infections through drug repurposing of synergistic combinations

(2019) Yu-Shan Cheng et al.   CURRENT OPINION IN PHARMACOLOGY

Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence

(2019) Eirini Christaki et al.   JOURNAL OF MOLECULAR EVOLUTION

Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas aeruginosa

(2019) Serge Ruden et al.   Frontiers in Microbiology

Fitness Tradeoffs of Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli

(2018) Prabh Basra et al.   Genome Biology and Evolution

The Opp (AmiACDEF) Oligopeptide Transporter Mediates Resistance of Serotype 2 Streptococcus pneumoniae D39 to Killing by Chemokine CXCL10 and Other Antimicrobial Peptides

(2018) Kevin E. Bruce et al.   JOURNAL OF BACTERIOLOGY

Biofilm formation - what we can learn from recent developments

(2018) T. Bjarnsholt et al.   JOURNAL OF INTERNAL MEDICINE

Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides

(2018) Ammar Almaaytah et al.   Infection and Drug Resistance

Antimicrobial synergy between mRNA targeted peptide nucleic acid and antibiotics in E. coli

(2018) Jaime I. Castillo et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application

(2018) Melanie Dostert et al.   Journal of Innate Immunity

Relationship Between Biofilm Formation and Antimicrobial Resistance in Gram-Negative Bacteria

(2018) Virginio Cepas et al.   Microbial Drug Resistance

Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies

(2018) Zheng Pang et al.   BIOTECHNOLOGY ADVANCES

LL-37-derived short antimicrobial peptide KR-12-a5 and its d -amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity

(2017) Eun Young Kim et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Activity of innate antimicrobial peptides and ivacaftor against clinical cystic fibrosis respiratory pathogens

(2017) Joanna E. Payne et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?

(2016) Thien B. Tran et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Escherichia colibiofilm: development and therapeutic strategies

(2016) G. Sharma et al.   JOURNAL OF APPLIED MICROBIOLOGY

Synergistic Effect of Membrane-Active Peptides Polymyxin B and Gramicidin S on Multidrug-Resistant Strains and Biofilms of Pseudomonas aeruginosa

(2015) Marina Berditsch et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Acyl carrier protein is a bacterial cytoplasmic target of cationic antimicrobial peptide LL-37

(2015) M.-C. Chung et al.   BIOCHEMICAL JOURNAL

Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens

(2015) Leo Lin et al.   EBioMedicine

Synergistic Effects of Antimicrobial Peptides and Antibiotics against Clostridium difficile

(2014) Sabine Nuding et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides

(2014) Sibel Dosler et al.   PEPTIDES

pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37

(2014) Mahmoud H. Abou Alaiwa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of Intracellular Expression of Antimicrobial Peptide LL-37 on Growth of Escherichia coli Strain TOP10 under Aerobic and Anaerobic Conditions

(2013) Wei Liu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria

(2013) Lorraine A Draper et al.   BMC MICROBIOLOGY

Pseudomonas aeruginosa Biofilms in Disease

(2013) Lawrence R. Mulcahy et al.   MICROBIAL ECOLOGY

Identification of Peptides Derived from the Human Antimicrobial Peptide LL-37 Active against Biofilms Formed by Pseudomonas aeruginosa Using a Library of Truncated Fragments

(2012) C. Nagant et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Modulation of exogenous antibiotic activity by host cathelicidin LL-37

(2010) KATARZYNA LESZCZYŃSKA et al.   APMIS

Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation

(2008) J. Overhage et al.   INFECTION AND IMMUNITY